Ric N. Price mainly focuses on Malaria, Plasmodium falciparum, Plasmodium vivax, Immunology and Artesunate. His Malaria research is multidisciplinary, incorporating elements of Internal medicine, Surgery and Drug resistance. His study in Plasmodium falciparum is interdisciplinary in nature, drawing from both Quinine, Multiple drug resistance, Pharmacology and Virology.
He has researched Plasmodium vivax in several fields, including Epidemiology, Chloroquine, Antimalarial Agent, Primaquine and Global health. His Immunology research includes elements of Endothelium and Lung injury. The study incorporates disciplines such as Mefloquine and Piperaquine in addition to Artesunate.
Ric N. Price spends much of his time researching Malaria, Plasmodium vivax, Plasmodium falciparum, Internal medicine and Immunology. He studies Parasitemia, a branch of Malaria. His Plasmodium vivax study combines topics in areas such as Epidemiology, Chloroquine, Primaquine, Plasmodium and Piperaquine.
His work carried out in the field of Plasmodium falciparum brings together such families of science as Drug resistance, Pharmacology and Virology. His research integrates issues of Gastroenterology and Dihydroartemisinin/piperaquine in his study of Internal medicine. His studies in Immunology integrate themes in fields like Endothelium and Asymptomatic.
Ric N. Price focuses on Malaria, Plasmodium vivax, Plasmodium falciparum, Internal medicine and Primaquine. His Malaria research includes themes of Hazard ratio and Virology. His Plasmodium vivax research incorporates themes from Epidemiology, Genotyping, Incidence and Pediatrics.
The Plasmodium falciparum study which covers Drug resistance that intersects with Mutation and Lineage. His biological study spans a wide range of topics, including Gastroenterology, Parasitemia and Artesunate. His Artemisinin study combines topics in areas such as Mefloquine and Pharmacology, Dosing.
His primary scientific interests are in Malaria, Plasmodium vivax, Plasmodium falciparum, Primaquine and Internal medicine. He specializes in Malaria, namely Plasmodium. His Plasmodium vivax research focuses on Incidence and how it connects with Transmission and Virology.
His study in Plasmodium falciparum is interdisciplinary in nature, drawing from both Pharmacology and Drug discovery. His Internal medicine research includes elements of Piperaquine, Dihydroartemisinin/piperaquine and Haemolysis. As part of one scientific family, Ric N. Price deals mainly with the area of Dihydroartemisinin/piperaquine, narrowing it down to issues related to the Chloroquine, and often Artesunate.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Vivax Malaria: Neglected and Not Benign
Ric N. Price;Emiliana Tjitra;Carlos A. Guerra;Shunmay Yeung.
American Journal of Tropical Medicine and Hygiene (2007)
Mefloquine resistance in Plasmodium falciparum and increased pfmdr1 gene copy number.
Ric N. Price;Ric N. Price;Anne Catrin Uhlemann;Alan Brockman;Rose McGready.
The Lancet (2004)
Multidrug-resistant Plasmodium vivax associated with severe and fatal malaria: a prospective study in Papua, Indonesia.
Emiliana Tjitra;Nicholas M Anstey;Paulus Sugiarto;Noah Warikar.
PLOS Medicine (2008)
Effects of artesunate-mefloquine combination on incidence of Plasmodium falciparum malaria and mefloquine resistance in western Thailand: a prospective study
F Nosten;F Nosten;M van Vugt;R Price;R Price;C Luxemburger;C Luxemburger.
The Lancet (2000)
Effects of artemisinin derivatives on malaria transmissibility
R.N Price;F Nosten;C Luxemburger;F.O ter Kuile.
The Lancet (1996)
A long neglected world malaria map: Plasmodium vivax endemicity in 2010.
Peter W. Gething;Iqbal R. F. Elyazar;Catherine L. Moyes;David L. Smith;David L. Smith.
PLOS Neglected Tropical Diseases (2012)
Artemether-lumefantrine treatment of uncomplicated Plasmodium falciparum malaria: a systematic review and meta-analysis of day 7 lumefantrine concentrations and therapeutic response using individual patient data
EA Ashley;F Aweeka;KI Barnes;Q Bassat.
BMC Medicine (2015)
The pathophysiology of vivax malaria
Nicholas M. Anstey;Bruce Russell;Bruce Russell;Bruce Russell;Tsin W. Yeo;Ric N. Price;Ric N. Price.
Trends in Parasitology (2009)
Factors contributing to anemia after uncomplicated falciparum malaria.
R N Price;J A Simpson;F Nosten;C Luxemburger.
American Journal of Tropical Medicine and Hygiene (2001)
New developments in Plasmodium vivax malaria: severe disease and the rise of chloroquine resistance.
Ric N Price;Nicholas M Douglas;Nicholas M Anstey.
Current Opinion in Infectious Diseases (2009)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: